Alzheimer's Society appoints new director

Dr Doug Brown has been announced as 's director of research and development.

Dr Brown will move from his post as head of biomedical research at the Multiple Sclerosis Society.

Inspired by a passion for research, Dr Doug Brown is Alzheimer’s Society’s latest weapon in the fight against dementia and he is determined to make life better for people with the condition.

Increasing investment is a key goal of the society which last year spent more than £3.5 million on research – a rise of 33 per cent. By 2017, Alzheimer’s Society aims to invest £10 million a year in dementia research.

Dr Brown said: “Alzheimer’s Society already has a hugely successful research programme and I’m very excited to have the opportunity to join the team to help build on those achievements.

“I aim to help take the research programme from strength to strength ensuring that it is always focussed on improving the lives of those living with dementia.

“The charity is a major player in research and I will continue to raise that profile nationally and internationally.

“We must work towards a future free of dementia – research is key in making that happen and although that may take time we won’t get there if we don’t aim for it.

“Alzheimer’s Society is uniquely placed. Having people living with dementia at the heart of the organisation ensures we fund the right research at the right time giving us the best chance of delivering life-changing results.”

Jeremy Hughes, chief executive of Alzheimer’s Society commented on Doctor Brown’s appointment: “The Society's strategy commits to major growth in our research both into Alzheimer’s disease and other forms of dementia as well as delivery of the best care and support.

“Doug brings top level skills in managing research and will work closely alongside Professor Clive Ballard, one of the world's leading dementia experts, who will continue to support the Society.”

Simon Gillespie, chief executive of the MS Society said: “Over the last four years, Doug has been instrumental in the development of our world class research programme, helping us fund truly ground-breaking research and building our influence in the wider MS research field.

“We thank Doug for his excellent work to help beat MS and wish him well in this fantastic new role at the Alzheimer’s Society. The MS Society and the Alzheimer’s Society will continue to push the boundaries of neuroscience to tackle these neurological conditions, and we will continue to work closely together on issues such as social care provision and funding.

“The MS Society’s ambitious research programme continues apace, as we focus on new, effective treatments to help people living with MS now and in the future.”